Autism Spectrum Disorder Trial, Recruiting (NCT07064967)

Autism Spectrum Disorder Trial, Recruiting NCT07064967 Sponsor: Guangzhou Women and Children's Medical Center Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT07064967 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Boys between 6 and 12 years old
Children who have been diagnosed with Autism Spectrum Disorder (ASD) based on standard diagnostic guidelines known as DSM-5
Children whose IQ score is above 70, as measured by a recognised cognitive test such as the Wechsler Intelligence Scale for Children
Children who are able to cooperate well enough to take part in brain scanning sessions called MEG experiments

Who may not be able to join:

Children who also have a neurological condition, a genetic syndrome, or a severe developmental disability alongside their autism diagnosis
Children who have any metal implants in their body that could interfere with the MEG brain scanning equipment
Children who are currently taking antipsychotic medications or sedatives

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-020-81886332

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07064967

Sponsor: Guangzhou Women and Children's Medical Center

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: +86-020-81886332

More information: https://clinicaltrials.gov/study/NCT07064967

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Boys between 6 and 12 years old
Children who have been diagnosed with Autism Spectrum Disorder (ASD) based on standard diagnostic guidelines known as DSM-5
Children whose IQ score is above 70, as measured by a recognised cognitive test such as the Wechsler Intelligence Scale for Children
Children who are able to cooperate well enough to take part in brain scanning sessions called MEG experiments

Who may not be able to join:

Children who also have a neurological condition, a genetic syndrome, or a severe developmental disability alongside their autism diagnosis
Children who have any metal implants in their body that could interfere with the MEG brain scanning equipment
Children who are currently taking antipsychotic medications or sedatives

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Guangzhou Women and Children's Medical Center

Registry

ClinicalTrials.gov

Start date

5 November 2024

Est. completion

31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Identification of Neural Oscillation Characteristics in Children with Autism Spectrum Disorder

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov